<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Paraoxonase-1 is a polymorphic enzyme that is strongly associated with circulating <z:chebi fb="6" ids="39025">high-density lipoproteins</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The absence of paraoxonase-1 in mice has been shown to promote diet-induced <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>As paraoxonase-1 has been recently shown to be a lactonase, its functional role remains to be fully elucidated </plain></SENT>
<SENT sid="3" pm="."><plain>We explored additional vascular changes in Pon1 knockout mice in the absence of atherogenic diet challenge </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Early steps in atherogenesis, namely, leukocyte rolling and firm <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, were measured using intravital microscopy </plain></SENT>
<SENT sid="5" pm="."><plain>Vascular oxidative status was determined by lucigenin-derived chemiluminescence </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0004420'>Arterial thrombosis</z:hpo> was determined by in vivo carotid <z:mp ids='MP_0005048'>thrombosis</z:mp> assay </plain></SENT>
<SENT sid="7" pm="."><plain>Gene expressions were determined by reverse transcription polymerase chain reaction </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: We observed a twofold increase in leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, but no significant change in leukocyte rolling in Pon1(-/-) mice versus <z:mp ids='MP_0002169'>wild-type</z:mp> controls </plain></SENT>
<SENT sid="9" pm="."><plain>This finding is correlated with a 1.6-fold increase in aortic <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of P-selectin (P&lt;.016), a 1.3-fold up-regulation in Vcam1 (P=.096), and a 1.5-fold up-regulation in Icam1 (P=.016) </plain></SENT>
<SENT sid="10" pm="."><plain>Aortic Tnfalpha <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was unchanged </plain></SENT>
<SENT sid="11" pm="."><plain>Pon1(-/-) mice were also found to show a threefold increase in aortic <z:chebi fb="1" ids="18421">superoxide</z:chebi> production rate (P=.04) </plain></SENT>
<SENT sid="12" pm="."><plain>Furthermore, carotid <z:mp ids='MP_0005048'>thrombosis</z:mp> assay revealed a 57% reduction in time to occlusion in Pon1(-/-) mice (P&lt;.001) </plain></SENT>
<SENT sid="13" pm="."><plain>In spite of such vascular proinflammatory phenotypes, we observed no change in plasma levels of inflammatory cytokines or in hepatic <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of serum amyloid A </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: Our data revealed significant vascular changes in <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and thrombotic tendencies in Pon1(-/-) mice in the absence of <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo> and systemic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>